Home › NDC Lookup › RxCUI directory › RxCUI 240912

Granisetron 1 MG/ML Injectable Solution — RxCUI 240912

Name: Granisetron 1 MG/ML Injectable Solution (RxCUI 240912)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 240912 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI240912

Official nameGranisetron 1 MG/ML Injectable Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asgranisetron 1 MG (as granisetron HCl 1.12 MG) per ML Injectable Solution; granisetron HCl 1 MG/ML Injectable Solution

FDA products mapped8

Package NDCs mapped8

Reported Medicaid activity (SDUD)33,883 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Granisetron: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Granisetron is an anti-nausea medicine. It's mainly used to prevent nausea and vomiting that cancer chemotherapy or radiation therapy can cause. Depending on which product you've b...
The Sancuso patch delivers granisetron slowly through your skin over up to 7 days — you apply it to your upper outer arm at least 24 hours before chemotherapy starts and leave it o...
How does the Sancuso patch work differently from the pill or injection?
The most common ones are headache and constipation — these are the side effects most often reported in clinical studies. Some people also notice fever, stomach pain, or a slight ch...

📖 Read our full Granisetron guide →

🕸️ Concept Web — How Granisetron 1 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Granisetron 1 MG/ML Injectable Solution RxCUI 240912 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Granisetron 26237 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Granisetron Injectable Solution 377124 SCDF
- Granisetron Injectable Product 1156890 SCDG
- Injectable Solution 316949 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Granisetron 1 MG/ML 328343 SCDC

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Granisetron 1 MG/ML SCDC · 328343
Granisetron Injectable Solution SCDF · 377124
Granisetron Injectable Product SCDG · 1156890

📦 FDA Products & Package NDCs

8 products · 8 package NDCs

8 package NDCs map to RxCUI 240912 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9744-10	10 VIAL, SINGLE-USE in 1 PACKAGE (0143-9744-10) / 1 mL in 1...	Granisetron Hydrochloride	Hikma Pharmaceuticals USA Inc.	2009-12-23
00143-9745-05	5 VIAL, MULTI-DOSE in 1 CARTON (0143-9745-05) / 4 mL in 1 V...	Granisetron Hydrochloride	Hikma Pharmaceuticals USA Inc.	2009-12-23
00143-9745-10	10 VIAL, MULTI-DOSE in 1 CARTON (0143-9745-10) / 4 mL in 1...	Granisetron Hydrochloride	Hikma Pharmaceuticals USA Inc.	2009-12-23
55150-0175-01	1 VIAL, SINGLE-DOSE in 1 CARTON (55150-175-01) / 1 mL in 1...	Granisetron Hydrochloride	Eugia US LLC	2016-07-06
55150-0176-04	1 VIAL, MULTI-DOSE in 1 CARTON (55150-176-04) / 4 mL in 1 V...	Granisetron Hydrochloride	Eugia US LLC	2016-07-06
63323-0318-01	1 VIAL, SINGLE-USE in 1 BOX (63323-318-01) / 1 mL in 1 VIAL...	Granisetron	Fresenius Kabi USA, LLC	2009-11-20
67457-0863-01	1 VIAL in 1 CARTON (67457-863-01) / 1 mL in 1 VIAL	Granisetron Hydrochloride	Mylan Institutional LLC	2018-03-21
67457-0864-04	1 VIAL in 1 CARTON (67457-864-04) / 1 mL in 1 VIAL	Granisetron Hydrochloride	Mylan Institutional LLC	2018-03-21

Observed labelers: Hikma Pharmaceuticals USA Inc. (3) · Eugia US LLC (2) · Mylan Institutional LLC (2) · Fresenius Kabi USA, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1626	Granisetron hcl injection	5	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.